The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback